The cryptocurrency market has shed more than $1 trillion since early October 2025, plunging from around $4.2 trillion to below $3 trillion following a wave of sell-offs and leveraged-position liquidations.
Author: Mikolaj Laszkiewicz
The U.S. public health agency has updated content on its website, stating that the claim “vaccines do not cause autism” is not evidence-based. The move has triggered a wave of criticism from experts and health organizations.
Precise Bio has announced the world’s first successful implantation of a lab-grown, 3D-bioprinted human cornea. The company describes the procedure as a “milestone” that could transform the treatment of corneal diseases worldwide.
In response to pressure from the tech industry and increasing competitive challenges from the U.S. and China, the European Union has proposed significant changes to two of its key legal frameworks: the General Data Protection Regulation (GDPR) and the AI Act. The revision introduces simpler rules for data processing, delays enforcement for “high-risk” AI systems, and eases restrictions on cookies.
U.S. lawmakers are considering reintroducing a moratorium on state AI regulations — this time by placing it inside the annual defense bill (NDAA), which is almost always passed. The moratorium aims to unify AI rules at the federal level and protect innovation, as many states have already enacted their own AI laws.
A new U.S. study shows that 13.1% of young people aged 12–21 use generative AI tools (such as ChatGPT or Google Gemini) for support when facing mental-health challenges. Particularly concerning is that among those who do use AI, 65.5% turn to it once a month or more, and 92.7% say the advice they receive is helpful.
A study published in JAMA Internal Medicine found that the Donald Trump administration terminated funding for 383 ongoing clinical trials, affecting more than 74,000 participants. The cuts were part of broader budget reductions at the National Institutes of Health.
Jeff Bezos has become co-CEO of a new AI startup called Project Prometheus, which has raised $6.2 billion in funding and has ambitious plans to deploy artificial intelligence in industrial sectors.
The U.S. Food and Drug Administration (FDA) has expanded approval for ONWARD Medical N.V.’s ARC‑EX System to include home use for adults with chronic, non-progressive neurological deficits following incomplete spinal cord injury.
A federal jury in California has ruled that Apple infringed on a Masimo patent related to blood-oxygen measurement technology in the Apple Watch and may have to pay up to $634 million in damages. The dispute concerns health-monitoring features that Masimo claims rely on its patented technology.
